Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 6, 1996, Pages 755-762

  Mowri, Hiro Omi ^a   Patsch, Josef R ^b,d   Gotto Jr , Antonio M ^a   Patsch, Wolfgang ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

apolipoprotein A II; hepatic lipase; high density lipoproteins; remnant catabolism

Indexed keywords

APOLIPOPROTEIN A2; FATTY ACID; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL;

ARTICLE; CATABOLISM; DENSITY; ENZYME SUBSTRATE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNORADIOMETRIC ASSAY; LIPID TRANSPORT; LIPOLYSIS; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 0030012443     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.6.755     Document Type: Article

References (67)

1. Jackson RL. Lipoprotein lipase and hepatic lipase. In Boyer P, ed. The Enzymes, Vol XVI. New York, NY: Academic Press Inc; 1983:141-181.
2. Kinnunen PKJ, Virtanen JA, Vaino P. Lipoprotein lipase and hepatic endothelial lipase: their roles in lipoprotein metabolism. Atheroscler Rev. 1983;11:65-105.
3. Hegele RA, Little A, Vezina C, Maguire GF, Tu L, Wolever TS, Jenkins DJA, Connelly PW. Hepatic lipase deficiency: clinical, biochemical and molecular genetic characteristics. Arterioscler Thromb. 1993;13:720-728.
4. Breckenridge WC, Little JA, Alaupovic P, Wang CS, Kuksis A, Kakis G, Lindgren F, Gardiner G. Lipoprotein abnormalities assoelated with a familial deficiency of hepatic lipase. Atherosclerosis. 1982;45:161-179.
5. Carlson LA, Holmquist L, Nilsson-Ehle P. Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-α-triglyceridemia. Acta Med Scand. 1986;219:435-447.
6. Demant T, Carlson LA, Holmquist L, Karpe F, Nilsson-Ehle P, Packard CJ, Shepherd J. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res. 1988;29:1603-1611.
7. Auwerx JH, Marzetta CA, Hokanson JE, Brunzell JD. Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis. 1989;9:319-325.
8. Goldberg U, Le N-A, Paterniti JR Jr, Ginsberg HN, Lindgren FT, Brown WV. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest. 1982;70:1184-1192.
9. Daggy BP, Bensadoun A. Enrichment of apolipoprotein B-48 in the LDL density class following in vivo inhibition of hepatic lipase. Biochim Biophys Acta. 1986;877:252-261.
10. Sultan F, Lagrange D, Jansen H, Griglio S. Inhibition of hepatic lipase activity impairs chylomicron remnant removal in rats. Biochim Biophys Acta. 1990;1042:150-152.
11. Brasaemle DL, Cornely-Moss K, Bensadoun A. Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E. J Lipid Res. 1993;34:455-465.
12. Shafi S, Brady SE, Bensadoun A, Havel RJ. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J Lipid Res. 1994;35:709-720.
13. Applebaum-Bowden D, Haffner SM, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Hazzard WR. Postheparin plasma triglyceride lipases: relationships with very low-density lipoprotein triglyceride and high-density lipoprotein 2 cholesterol. Arteriosclerosis. 1985;5:273-282.
14. Kuusi T, Kesaniemi YA, Vuoristo M, Miettinen TA, Koskenvuo M. Inheritance of high-density lipoprotein and lipoprotein lipase and hepatic lipase activity. Arteriosclerosis. 1987;7:421-425.
15. 2: relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest. 1987;80:341-347.
16. 2 subfraction with hepatic lipase. J Lipid Res. 1992;33:1269-1279.
17. 3 by hepatic lipase. J Clin Invest. 1984;74:2017-2023.
18. Patsch JR, Patsch W. Zonal ultracentrifugation. Methods Enzymol. 1986;129:3-21.
19. Cheung MC, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography: particles containing A-I but no A-II. J Biol Chem. 1984;255:3178-3185.
20. Silberman SR, Bernini F, Sparrow JT, Gotto AM Jr, Smith LC. Monoclonal antibodies as probes of high-density lipoprotein structure: identification and localization of a lipid-dependent epitope. Biochemistry. 1987;26:5833-5843.
21. Mowri H-O, Patsch JR, Ritsch A, Foger B, Brown S, Patsch W. High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase. J Lipid Res. 1994;35:291-300.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
23. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem. 1959;234:466-468.
24. Nagele U, Hagele EO, Sauer G, Wiedermann E, Lehmann P, Wahlefeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984;22:165-174.
25. Siedel J, Hagele E, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29:1075-1080.
26. Blanche PJ, Gong EL, Forte T, Nichols AV. Characterization of human high density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta. 1981;381:233-241.
27. Neville DM. Molecular weight determination of protein dodecyl complexes by gel electrophoresis in a discontinuous buffer system. J Biol Chem. 1971;246:6328-6334.
28. Warnick GR, Mayfield C, Albers JJ, Hazzard WR. Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3. Clin Chem. 1979;25:279-284.
29. Patsch W, Kim K, Wiest W, Schonfeld G. Effects of sex hormones on rat lipoproteins. Endocrinology. 1980;107:1085-1094.
30. Van Tornout P, Caster H, Lievens M-J, Rosseneu M, Assmann G. In vitro interaction of human HDL with human apolipoprotein A-II. Biochim Biophys Acta. 1981;663:630-636.
31. Ehnholm C, Kuusi T. Preparation, characterization, and measurement of hepatic lipase. Methods Enzymol. 1986;129:716-738.
32. McFarlane AS. Efficient trace-labeling of proteins with iodine. Nature. 1958;182:53-57.
33. Patsch W, Patsch JR, Kostner GM, Sailer S, Braunsteiner H. Isolation of subfractions of human very low density lipoproteins by zonal ultracentrifugation. J Biol. Chem. 1978;253:4911-4915.
34. Huttunen JK, Ehnholm C, Kinnunen PKT, Nikkila EA. An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta. 1975;63:335-347.
35. Ritsch A, Auer B, Foger B, Schwarz S, Patsch JR. Polyclonal antibody-based immunoradiometric assay for quantification of cholesteryl ester transfer protein. J Lipid Res. 1993;34:673-679.
36. 2-phospholipids and triglycerides by hepatic lipase. Biochem Biophys Res Commun. 1981;100:591-599.
37. Laboda HN, Glick JM, Phillips MC. Influence of the structure of the lipid-water interface on the activity of hepatic lipase. Biochemistry. 1988;27:2313-2319.
38. Behr SR, Patsch JR, Forte T, Bensadoun A. Plasma lipoprotein changes resulting from immunologically blocked lipolysis. J Lipid Res. 1981;22:443-451.
39. Whitlock ME, Swenson TL, Ramakrishnan T, Leonard MT, Marcel YL, Milne RW, Tall AR. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit: effects on lipoprotein composition and high-density lipoprotein cholesteryl ester metabolism. J Clin Invest. 1989;84:129-137.
40. Cheung MC, Wolf AC. In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase. J Lipid Res. 1989;30:499-509.
41. Jahn CE, Osborne JC Jr, Schaefer EJ, Brewer HB Jr. Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II: characterization of a major component of high density lipoprotein as the activating plasma component in vitro. Eur J Biochem. 1983;131:25-29.
42. 2-triacylglycerols. Biochim Biophys Acta. 1982;713:292-299.
43. Kubo M, Matsuzawa Y, Tajima S, Ishikawa K, Yamamoto A, Tarui S. ApoA-I and apoA-II inhibit hepatic triglyceride lipase from human postheparin plasma. Biochem Biophys Res Commun. 1981;100:261-266.
44. Thuren T, Wilcox RW, Sisson P, Waite M. Hepatic lipase hydrolysis of lipid monolayers: regulation by apolipoproteins. J Biol Chem. 1991;266:4853-4861.
45. Thuren T, Weisgraber KH, Sisson P, Waite M. Role of apolipoprotein E in hepatic lipase catalyzed hydrolysis of phospholipid in high-density lipoproteins. Biochemistry. 1992;31:2332-2338.
46. Landis BA, Rotolo FS, Meyers WC, Clark AB, Quarfordt SH. Influence of apolipoprotein E on soluble and heparin-immobilized hepatic lipase. Am J Physiol. 1987;252:G805-G810.
47. Gotto AM Jr, Pownall HJ, Havel RJ. Introduction to plasma lipoproteins. Methods Enzymol. 1986;128:3-41.
48. Weisgraber KH, Mahley RW. Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography. J Lipid Res. 1980;21:316-325.
49. Rader DJ, Ikewaki K, Duverger N, Schmidt H, Pritchard H, Frohlich J, Clerc M, Dumon M-F, Fairwell T, Zech L, Santamarina-Fojo S, Brewer HB Jr. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing apoA-II in classic lecithin:cholesterol acyltransferase deficiency and fish-eye disease. J Clin Invest. 1994;93:321-330.
50. Marques-Vidal P, Azema C, Collet X, Vieu C, Chap H, Perret B. Hepatic lipase promotes the uptake of HDL esterified cholesterol by the perfused rat liver: a study using reconstituted HDL particles of defined phospholipid composition. J Lipid Res. 1994;35:373-384.
51. Jansen H, de Greef WJ. Heparin-releasable lipase activity of rat adrenals. Biochem J. 1981;196:739-745.
52. Hixenbaugh EZ, Sullivan TR Jr, Strauss JF, Laposata EA, Komaromy M, Paavola LG. Hepatic lipase in rat ovary: ovaries cannot synthesize hepatic lipase but accumulate it from the circulation. J Biol Chem. 1989;264:4222-4230.
53. Fager G, Wiklund O, Olofsson SO, Wilhelmsen L, Bjonders G. Multivariate analysis of serum apolipoproteins and risk factors in relation to acute myocardial infarction. Arteriosclerosis. 1981;1:273-279.
54. Deeb SS, Takata K, Peng R, Kajiyama G, Albers JJ. A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am J Hum Genet. 1990;46:822-827.
55. Mehrabian M, Quia H-H, Hyman R, Ruddle D, Laughton C, Lusis AJ. Influence of apoA-II gene locus on HDL levels and fatty streak development in mice. Arterioscler Thromb. 1993;13:1-10.
56. Schultz JR, Verstuyft JG, Gong EL, Nichols AV, Rubin EM. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature. 1993;21:762-764.
57. Warden CH, Hedrick CC, Quiao J-H, Castellani LW, Lusis AJ. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 1993;261:469-472.
58. Puchois P, Kandoussi A, Fievet P, Fourrier JL, Bertrand M, Koren E, Fruchart JC. Apolipoprotein A-I-containing lipoproteins in coronary artery disease. Atherosclerosis. 1987;68:35-40.
59. Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste-Blazy P, Luc G, Richard JL, Ducimetière P, Fruchart JC, Cambien F. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: the ECTIM study. Arterioscler Thromb. 1992;12:701-707.
60. Genest JJ, Bard JM, Fruchart J-C, Ordovas JM, Wilson PFW, Schaefer EJ. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease. Atherosclerosis. 1991;90:149-158.
61. Montali A, Vega GL, Grundy SM. Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia. Arterioscler Thromb. 1994;14:511-517.
62. II particles. Biochem Biophys Res Commun. 1987;142:63-69.
63. Johnson WJ, Kilsdonk EPC, van Tol A, Phillips MC, Rothblat GH. Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII. J Lipid Res. 1991;32:1993-2000.
64. Oikawa S, Mendez AJ, Oram JF, Bierman EL. Effects of high-density lipoprotein particles containing apoA-I, with or without apoA-II, on intracellular cholesterol efflux. Biochim Biophys Acta. 1993;1165:327-334.
65. Ohta T, Nakamura R, Ikeda Y, Shinohara M, Miyazaki A, Horiuchi S, Matsuda I. Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin:cholesterol acyltransferase. Biochim Biophys Acta. 1993;1165:119-128.
66. Zhong S, Goldberg U, Bruce C, Rubin E, Breslow JL, Tall A. Human apoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. J Clin Invest. 1994;94:2457-2467.
67. Phillips MC. Interactions of apolipoproteins at interfaces. In: Rosseneu M, ed. Structure and Function of Apolipoproteins. Boca Raton, Fla: CRC Press, Inc; 1992:185-216.